MA
MDT icon

MCF Advisors’s Medtronic MDT Stock Holding History

MCF Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Buy
3,829
+3,147
+461% +$301K 0.01% 315
2025
Q4 		$66K Sell
682
-374
-35% -$36.3K ﹤0.01% 469
2025
Q3 		$101K Buy
1,056
+25
+2% +$2.3K 0.01% 320
2025
Q2 		$90.1K Sell
1,031
-148
-13% -$12.6K 0.01% 323
2025
Q1 		$106K Sell
1,179
-216
-15% -$19.3K 0.01% 298
2024
Q4 		$112K Buy
1,395
+259
+23% +$22.4K 0.01% 295
2024
Q3 		$103K Sell
1,136
-398
-26% -$33.5K 0.01% 295
2024
Q2 		$121K Buy
1,534
+456
+42% +$37.4K 0.01% 282
2024
Q1 		$94.2K Buy
1,078
+11
+1% +$939 0.01% 302
2023
Q4 		$88.1K Buy
1,067
+13
+1% +$991 0.01% 310
2023
Q3 		$82.8K Buy
1,054
+51
+5% +$4.27K 0.01% 312
2023
Q2 		$88.5K Buy
1,003
+310
+45% +$26.7K 0.01% 306
2023
Q1 		$55.8K Sell
693
-1
-0.1% -$82 0.01% 337
2022
Q4 		$53.9K Sell
694
-462
-40% -$37.4K 0.01% 335
2022
Q3 		$94K Sell
1,156
-465
-29% -$41.8K 0.01% 272
2022
Q2 		$145K Buy
1,621
+718
+80% +$72.7K 0.02% 216
2022
Q1 		$100K Hold
903
– – 0.01% 261
2021
Q4 		$93K Sell
903
-12
-1% -$1.39K 1.99% 9
2021
Q3 		$115K Buy
915
+57
+7% +$7.38K 0.01% 232
2021
Q2 		$106K Hold
858
– – 0.01% 224
2021
Q1 		$101K Hold
858
– – 0.01% 215
2020
Q4 		$100K Buy
858
+29
+3% +$3.19K 0.01% 188
2020
Q3 		$86K Buy
829
+194
+31% +$19.5K 0.01% 199
2020
Q2 		$58K Sell
635
-25
-4% -$2.4K 0.01% 217
2020
Q1 		$59K Buy
660
+14
+2% +$1.49K 0.01% 219
2019
Q4 		$73K Buy
646
+599
+1,274% +$65.7K 0.01% 213
2019
Q3 		$5K Hold
47
– – ﹤0.01% 393
2019
Q2 		$5K Buy
+47
New +$4.29K ﹤0.01% 384
2019
Q1 		– Sell
-70
Closed -$6K – 473
2018
Q4 		$6K Sell
70
-65
-48% -$6.07K ﹤0.01% 388
2018
Q3 		$13K Hold
135
– – ﹤0.01% 340
2018
Q2 		$12K Hold
135
– – ﹤0.01% 323
2018
Q1 		$11K Hold
135
– – ﹤0.01% 331
2017
Q4 		$11K Sell
135
-34
-20% -$2.72K ﹤0.01% 333
2017
Q3 		$13K Buy
169
+135
+397% +$11.2K ﹤0.01% 323
2017
Q2 		$3K Sell
34
-257
-88% -$21.7K ﹤0.01% 427
2017
Q1 		$23K Buy
291
+257
+756% +$20.1K ﹤0.01% 300
2016
Q4 		$2K Hold
34
– – ﹤0.01% 410
2016
Q3 		$3K Hold
34
– – ﹤0.01% 402
2016
Q2 		$3K Hold
34
– – ﹤0.01% 437
2016
Q1 		$3K Sell
34
-416
-92% -$31.3K ﹤0.01% 397
2015
Q4 		$35K Sell
450
-108
-19% -$8.13K 0.01% 208
2015
Q3 		$37K Sell
558
-62
-10% -$4.57K 0.01% 204
2015
Q2 		$46K Hold
620
– – 0.01% 189
2015
Q1 		$48K Buy
+620
New +$47K 0.01% 191
2014
Q4 		– Sell
-558
Closed -$34K – 427
2014
Q3 		$34K Hold
558
– – 0.01% 203
2014
Q2 		$34K Hold
558
– – 0.01% 198
2014
Q1 		$34K Hold
558
– – 0.01% 210
2013
Q4 		$34K Sell
558
-51
-8% -$2.89K 0.01% 186
2013
Q3 		$37K Buy
609
+51
+9% +$2.74K 0.02% 194
2013
Q2 		$34K Buy
+558
New +$27.6K 0.02% 178

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MCF Advisors's MDT Position: Q1 2026 in Review

MCF Advisors increased its Medtronic (MDT) stake by 461% in Q1 2026, buying an estimated $301K and bringing the position to 3,829 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #315.

MCF Advisors first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • MCF Advisors held 3,829 shares of Medtronic worth $334K as of Q1 2026.
  • MCF Advisors bought 3,147 Medtronic shares in Q1 2026, an estimated $301K.
  • Medtronic made up 0.01% of MCF Advisors's portfolio in Q1 2026, its #315 holding.
  • MCF Advisors first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.